Spots Global Cancer Trial Database for follicular lymphoma grade iiia
Every month we try and update this database with for follicular lymphoma grade iiia cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
Umbralisib and Rituximab as Initial Therapy for Patients With Follicular Lymphoma and Marginal Zone Lymphoma | NCT03919175 | Lymphoma Follicular Lymp... Follicular Lymp... Follicular Lymp... Follicular Lymp... Marginal Zone L... Marginal Zone B... | Umbralisib Rituximab | 18 Years - | Massachusetts General Hospital | |
Ibrutinib for Patients With Follicular Lymphoma Without Complete Response to Initial Chemoimmunotherapy | NCT02966730 | Follicular Lymp... Follicular Lymp... Follicular Lymp... Follicular Lymp... | Ibrutinib | 18 Years - | Memorial Sloan Kettering Cancer Center |